Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Clinical-stage Therapeutics Company Announces Potential License Agreement

BioRestorative Therapies in Substantive Discussions for Potential License Agreement for ThermoStem® Metabolic Disease Program.
BioRestorative Therapies, Inc. (NASDAQ:BRTX), a clinical-stage company focused on stem cell-based therapies, has announced that it is currently engaged in substantive discussions with an undisclosed commercial-stage regenerative medicine company. These discussions concern a potential licensing agreement for BioRestorative’s allogeneic, off-the-shelf ThermoStem® metabolic disease intellectual property. This development marks a significant step for BioRestorative as it aims to bring its innovative therapeutic solutions closer to commercialization. $Biorestorative Therapies(BRTX.US)$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
4548 Views
Comment
Sign in to post a comment
    178Followers
    0Following
    400Visitors
    Follow